Biocon And Viatris Ready To Launch EU Bevacizumab

Biocon Biologics Announces Formal EU Approval For Abevmy Biosimilar

 
• By David Wallace
EU Europe Flag Biosimilar Vaccine
Biocon and Viatris have received formal EU approval for Abevmy • Source: Alamy

More from Biosimilars

More from Products